Clicky

Cytokinetics, Incorporated(CYTK) News

Date Title
Jun 20 Cytokinetics Announces Start of MAPLE-HCM, a Phase 3 Clinical Trial of Aficamten Compared to Metoprolol in Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Apr 27 Cytokinetics (CYTK) Expected to Beat Earnings Estimates: Can the Stock Move Higher?